CoChat

Quality of compounded hydrocortisone capsules used in the treatment of children

Open access

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Due to the lack of paediatric-licensed formulations, children are often treated with individualized pharmacy-compounded adult medication. An international web-based survey about the types of medication in children with adrenal insufficiency (AI) revealed that the majority of paediatric physicians are using pharmacy-compounded medication to treat children with AI. Observations of loss of therapy control in children with congenital adrenal hyperplasia with compounded hydrocortisone capsules and regained control after prescribing a new hydrocortisone batch led to this 'real world' evaluation of pharmacy-compounded paediatric hydrocortisone capsules. METHODS: Capsule samples were collected randomly from volunteering parents of treated children suffering from congenital adrenal hyperplasia from all over Germany. Analysis of net mass and hydrocortisone content by high-performance liquid chromatography with ultraviolet (HPLC-UV) detection method was performed based on the European Pharmacopeia. RESULTS: In a total of 61 batches that were sent, 5 batches could not be analysed because of missing dose information, insufficient number of capsules or were not possible to be evaluated. Fifty-six batches containing 1125 capsules were evaluated. 21.4% of the batches revealed insufficiency in uniformity of net mass or drug content and additional 3.6% failed because they did not contain the labelled drug. CONCLUSIONS: Compounded medication is a possible cause of variation of steroid doses in children with adrenal insufficiency or congenital adrenal hyperplasia, putting these vulnerable patients at risk of poor disease control and adrenal crisis. These data may apply to other individualized compounded oral medication as well, emphasizing the need for development of licensed paediatric formulations approved by regulatory authorities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-17-0248

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 8

  1. 2015, Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency, Journal of Clinical Endocrinology and Metabolism, 100, 1681, 10.1210/jc.2014-4060 · DOI · Paper page
  2. 2015, Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital, PLoS ONE, 10, e0120630, 10.1371/journal.pone.0120630 · DOI
  3. CaHASE, Kingdom Congenital Adrenal Hyperplasia Adult Study Executive Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia : United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive of Clinical Endocrinology, Journal Metabolism, 201499, 10.1210/jc.2014-1486 · DOI · Paper page
  4. 2013, HPLC method development to determine hydrocortisone from capsules contributing to a medication safety study., Annual Meeting of the German Pharmaceutical Society: DPhG
  5. 2012, Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia, Journal of Clinical Endocrinology and Metabolism, 97, 4429, 10.1210/jc.2012-2102 · DOI · Paper page
  6. 2013, HPLC method development to determine hydrocortisone from capsules contributing to a medication safety study., Annual Meeting of the German Pharmaceutical Society: DPhG
  7. 2000, Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children, BMJ, 320, 79, 10.1136/bmj.320.7227.79 · DOI · Paper page
  8. 2013, Potential risks of pharmacy compounding, Drugs in R&D, 13, 1, 10.1007/s40268-013-0005-9 · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Neumann, U., Burau, D., Spielmann, S., Whitaker, M. J., Ross, R. J., Kloft, C., & Blankenstein, O.
Affiliations
  • Charité – Universitätsmedizin Berlin (DE)
  • Freie Universität Berlin (DE)
  • University of Sheffield (GB)
Corresponding author
Blankenstein, Oliver
Venue
European Journal of Endocrinology
Published
2017-08
Volume
177
Issue
2
Pages
239-242
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2616786361
Cited by
56
References
6
Citations by year
2026: 5 · 2025: 6 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 2
FWCI
4.32
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Funders
European Commission (281654)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
Keywords
cortisol, pharmaceutical compounding, congenital adrenal hyperplasia, adrenal insufficiency, drug quality, drug content uniformity, adrenal crisis, pediatric formulations
MeSH terms
Adrenal Insufficiency, Capsules, Chemistry, Pharmaceutical, Child, Dose-Response Relationship, Drug, Drug Compounding, Germany, Humans, Hydrocortisone, Random Allocation, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quality of compounded hydrocortisone capsules used in the treatment of children. https://app.cochat.ai/papers/10.1530/eje-17-0248
The paper
Neumann, U., Burau, D., Spielmann, S., Whitaker, M. J., Ross, R. J., Kloft, C., & Blankenstein, O. (2017). Quality of compounded hydrocortisone capsules used in the treatment of children. European Journal of Endocrinology. https://doi.org/10.1530/eje-17-0248

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.